Across TCGA pan-cancer cohorts, MIR613 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of MIR613’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where MIR613 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR613 is over-expressed in tumor.

BRCA, COAD, and KIRC are the cancer types where MIR613 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR613 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	All	+0.195	<.001	4	view →
COAD	All	All	+0.241	.022	3	view →
KIRC	All	All	+0.047	.049	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: MIR613 RNA expression & survival · all MIR613 data types